09-21
Sat
16:54-17:18
分会场3：江海厅
淋巴肿瘤会场8
16:54-17:02
观看视频
Time to Lymphoma Treatment Within 24 Months in “Watch and Wait” Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis
17:02-17:10
观看视频
A prospective study of orelabrutinib plus obinutuzumab (O2) in treatment-naïve marginal zone lymphoma (MZL): preliminary analysis on efficacy and safety
17:10-17:18
观看视频
Understanding the molecular landscape of follicular lymphoma histologic grading: from genomic to Transcriptome Analysis
